A non-contagious autoimmune condition affecting 1–2% of India's population, treated with evidence-based phototherapy, medical therapy, and surgical techniques at DermaVue's 7 clinics across Kerala & Tamil Nadu.
7 clinics · Kerala & Tamil Nadu · ₹300 consultation
Vitiligo occurs when the immune system attacks melanocytes — the cells that produce skin pigment — causing well-defined white patches on the skin. In India, where most people have Fitzpatrick IV–VI skin tones, the contrast between affected and unaffected skin is especially visible, often leading to significant social stigma and psychological distress. Vitiligo is not contagious, not caused by diet, and not a sign of any internal disease. DermaVue dermatologists combine targeted phototherapy, immunomodulatory medications, and surgical melanocyte transfer techniques to stabilise the disease and restore pigment — tailored to each patient's disease stage, body site, and skin type.
Vitiligo is an acquired, chronic depigmentation disorder characterised by selective destruction of epidermal melanocytes, resulting in well-circumscribed, chalk-white macules and patches. Pathogenesis involves a convergence of autoimmune (CD8+ T-cell–mediated cytotoxicity), oxidative stress (elevated H2O2 and reduced catalase activity), neural, and genetic mechanisms.[1] The autoimmune model is supported by association with thyroid autoimmunity, type 1 diabetes mellitus, and pernicious anaemia. Clinically subtyped as non-segmental (generalised, acrofacial, universal) and segmental (dermatomal distribution, earlier onset, rapid stabilisation). Indian Fitzpatrick IV–VI skin phenotypes exhibit higher cosmetic impact and psychosocial burden due to stark contrast between depigmented and normally pigmented skin, necessitating aggressive repigmentation strategies including NB-UVB phototherapy, topical calcineurin inhibitors, and surgical non-cultured epidermal cell suspension (NCES) grafting.[2]
Symptoms range widely in severity. Identifying which type you have determines the right treatment.
Multiple factors act together — understanding them helps prevent recurrence after treatment.
A structured clinical assessment — not a quick glance and a prescription pad. Here's exactly what to expect.
All procedures by board-certified MD DVL dermatologists. US-FDA approved equipment. No technician-only protocols — ever.
Results are gradual, progressive, and lasting with the right protocol.
No, vitiligo is absolutely not contagious. It cannot spread through touch, sharing food, swimming together, or any form of physical contact. Vitiligo is an autoimmune condition where the body's own immune system attacks pigment-producing cells. The widespread misconception that vitiligo is contagious — sometimes wrongly linked to leprosy in Indian communities — has no medical basis whatsoever.
Vitiligo spreads when the autoimmune attack on melanocytes is active. Triggers for spreading include psychological stress, skin injuries (Koebner phenomenon), severe sunburn, and exposure to phenolic chemicals. Thyroid dysfunction, if untreated, can also drive disease activity. Oral mini-pulse corticosteroid therapy can arrest spread in 80–90% of cases within 3 months. Early dermatologist intervention during active spread is critical to limiting extent.
There is currently no permanent cure that eliminates the underlying autoimmune predisposition. However, significant repigmentation — often 70–90% colour restoration — is achievable with NB-UVB phototherapy, topical immunomodulators, and surgical melanocyte transfer in stable cases. Facial vitiligo responds best; acral areas (fingertips, toes) are most resistant. Maintenance therapy reduces relapse risk. Research into JAK inhibitors and targeted biologics is advancing rapidly.
DermaVue consultation fee is ₹300 at most branches. NB-UVB phototherapy session costs range from ₹500–1,500 per session depending on body area, with a typical course of 24–48 sessions. Excimer laser sessions range from ₹1,500–3,500 per session. Surgical melanocyte transfer costs depend on the area being treated and are discussed after stability assessment. All costs are explained transparently at your first consultation — no hidden charges.
Vitiligo itself does not affect physical health or life expectancy. However, it is associated with a higher incidence of other autoimmune conditions — particularly thyroid disorders (15–20% of patients), type 1 diabetes, and pernicious anaemia. DermaVue protocols include baseline and annual autoimmune screening to detect and manage any associated conditions early. The most significant health impact of vitiligo is psychological — depression, anxiety, and social withdrawal are common and addressed as part of comprehensive care.
Kerala's environment presents specific considerations: rubber plantation workers are exposed to phenolic compounds (para-tertiary-butylphenol) used in rubber processing, which can trigger chemical leukoderma. Intense tropical sun exposure without protection can cause sunburn that triggers Koebner phenomenon in predisposed individuals. Kerala also has a higher background prevalence of autoimmune thyroid disease, which is a known vitiligo co-morbidity. DermaVue dermatologists assess occupation, sun exposure patterns, and thyroid status as standard practice.
Board-certified MD DVL dermatologists across 7 clinics in Kerala & Tamil Nadu. WhatsApp for instant appointment. Consultation ₹300.
₹300 consultation · No hidden charges · 7 locations